
Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
PMN | Toronto | CAD | Real-time | |
PMN | NEO | CAD | Real-time | |
23J | Frankfurt | EUR | Delayed |
For the fiscal year ended 31 December 2021, Promis Neurosciences Inc revenues increased from C$2K to C$16K. Net loss increased from C$5.7M to C$11.8M. Revenues reflect Services and Sales increase from C$2K to C$10K. Higher net loss reflects Research and development increase of 98% to C$6.3M (expense), General expenses increase of 73% to C$4.2M (expense). Basic Earnings per Share excluding Extraordinary Items decreased from -C$0.02 to -C$0.03.
Period Ending: | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
---|---|---|---|---|
Total Revenue | 0.01 | 0.01 | 0 | 0 |
Gross Profit | ||||
Operating Income | -6.52 | -2.04 | -1.38 | -0.58 |
Net Income | -2.93 | -0.96 | -0.3 | -7.6 |
Period Ending: | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
---|---|---|---|---|
Total Assets | 22.46 | 29.22 | 7.82 | 9.39 |
Total Liabilities | 14.98 | 19.6 | 16.62 | 18.07 |
Total Equity | 7.48 | 9.62 | -8.8 | -8.68 |
Period Ending: | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
---|---|---|---|---|
Period Length: | 12 Months | 9 Months | 6 Months | 3 Months |
Cash From Operating Activities | -11.84 | -6.12 | -2.85 | -0.98 |
Cash From Investing Activities | 0.12 | -0 | ||
Cash From Financing Activities | 32.13 | 31.6 | 8.74 | 8.74 |
Net Change in Cash | 20.41 | 25.48 | 5.89 | 7.76 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review